1470nm激光联合径向光纤腔内激光消融大/小隐静脉功能不全的长期结果良好
该横断面调查评估了2008-2009年接受1470nm二极管激光联合径向光纤EVLA治疗的患者,平均随访114个月后复查203例(161例GSV、42例SSV功能不全)。仅1例(0.5%)GSV主干再通,98%患者无症状或显著改善,CEAP C分级和VCSS均显著下降。
要点
- 1470nm激光联合径向光纤EVLA治疗GSV/SSV功能不全约10年随访结果稳定。
- 仅0.5%(95%CI 0.0-2.7)的GSV主干再通,98%患者无症状或显著改善。
- GSV交界处最大直径与治疗后主干或前副大隐静脉反流独立相关(OR 1.10,95%CI 1.01-1.21)。
核心结论
- 1470nm二极管激光联合径向光纤EVLA对GSV或SSV功能不全均提供稳定且良好的长期结果。
研究设计与样本
- 2018年对2008-2009年在本三级中心接受EVLA的门诊患者进行横断面调查,240例合格患者中203例再评估(161例GSV、42例SSV功能不全),平均随访114个月(标准差11个月)。
主要发现
- 仅1例(0.5%;95%CI 0.0-2.7)接受治疗的GSV主干再通,该患者无症状。
- 高达98%的患者在EVLA后无症状或显著改善。
- GSV功能不全组21%、SSV功能不全组5%的患者接受了后续额外治疗。
- GSV组2例并发症(静脉曲张性静脉炎、隐神经损伤),SSV组1例并发症(静脉曲张性静脉炎)。
- GSV功能不全组CEAP C分级均值3.2 vs 1.5(P=.00001)、VCSS均值6.3 vs 1.6(P=.001);SSV功能不全组C分级均值2.9 vs 1.1(P=.00001)、VCSS均值5.4 vs 0.7(P=.001),随访结束时均显著降低。
关键数值与推荐
- 主干消融定义为B超不可见,或可见但不可压闭、彩色多普勒无血流或反流。
- 任何复发静脉曲张且漏点位于治疗段隐静脉者视为失败。
临床怎么用
- 1470nm激光联合径向光纤EVLA可作为GSV或SSV功能不全的长期有效治疗选择。
- 术后约10年仍需关注GSV交界处直径较大者的主干或前副大隐静脉反流风险。
局限性
- 为单中心横断面调查,仅203例完成再评估,可能存在选择偏倚。
- 原始240例中5例死亡、20例拒绝参与、12例失访。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: Scarce information is available on the long-term results of endovenous laser ablation (EVLA) for great saphenous vein (GSV) or small saphenous vein (SSV) insufficiency. We sought to provide data on the status of patients at least 9 years after EVLA. METHODS: In 2018, we undertook a cross-sectional survey of ambulatory patients who had undergone EVLA in our tertiary care center in 2008-2009. Of 240 eligible patients, 5 died of causes not related to EVLA, 20 refused to participate, and 12 were lost to follow-up. Thus, 203 patients were re-evaluated; of them, 161 (79%) had GSV insufficiency and 42 (21%) had SSV insufficiency. The mean follow-up was 114 months (standard deviation, 11 months). All included patients underwent an echocardiography-color Doppler (ECD) evaluation, a clinical visit, and a standardized medical history. We assessed the competence of the junction and of the treated and untreated saphenous trunk and the presence of recurrent varicose veins. The trunk was considered ablated if it was nonvisible on B-mode or, when visible, if it was noncompressible or without flow or reflux on color flow Doppler analysis. Any recurrent varicose vein with the leakage point located in the treated saphenous vein was considered a failure. We asked patients about the effect of EVLA on their preoperative complaints and about any new or recurrent symptoms. We also recorded any complication or additional subsequent treatment and all data necessary to calculate the clinical class (C of the Clinical, Etiology, Anatomy, and Pathophysiology [CEAP] classification) and the Venous Clinical Severity Score (VCSS). Finally, we investigated potential associations between the study outcomes and variables by multiple logistic regression techniques. RESULTS: Some 10 years after EVLA, we performed a single clinical and ECD evaluation in 203 patients. Only one recanalization (0.5%; 95% confidence interval, 0.0-2.7) of the treated GSV trunk was observed in an otherwise asymptomatic patient. Up to 98% of patients were asymptomatic or significantly improved after EVLA. Additional subsequent treatments occurred in 21% of patients with GSV insufficiency and 5% of patients with SSV insufficiency. Three complications were observed, two in the GSV group (varicophlebitis, saphenous nerve damage) and one (varicophlebitis) in the SSV group. The mean C class of CEAP and the mean VCSS were significantly lower at the end of follow-up, both in patients with GSV insufficiency (C class, 3.2 vs 1.5 [P = .00001]; VCSS, 6.3 vs 1.6 [P = .001]) and in patients with SSV insufficiency (C class, 2.9 vs 1.1 [P = .00001]; VCSS, 5.4 vs 0.7 [P = .001]). Only the maximum diameter of the GSV at the junction independently correlated with ECD-confirmed reflux in the treated saphenous trunk or in the anterior accessory saphenous vein (odds ratio, 1.10; 95% confidence interval, 1.01-1.21). CONCLUSIONS: EVLA using a 1470-nm diode laser with radial fibers provides stable and valuable long-term results in patients with either GSV or SSV insufficiency.
引用
- Pavei P, Spreafico G, Bernardi E, et al. Favorable long-term results of endovenous laser ablation of great and small saphenous vein incompetence with a 1470-nm laser and radial fiber. J Vasc Surg Venous Lymphat Disord. 2020. PMID: 32599308. doi:10.1016/j.jvsv.2020.06.015
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。